Evaluation of HARMONi-2 Trial Discussions and Hype Analysis: Ivonescimab (Summit/Akeso) vs. Pembroli...
KOL Pulse Oncology Trends
This Sunday, September 8, the HARMONI-2 Trial data will be presented at World Lung by Akeso, a China...
by Brian Shields The LUNAR trial is a phase 3 clinical trial that evaluated the safety and effective...
Prepare your Tech for the Social Discussions at #ASCO24 With #ASCO24 approaching, now is a great tim...
The Digital KOLs of #ASH23 The American Society of Hematology’s annual meeting brings together the b...
In today's healthcare industry, Key Opinion Leaders (KOLs) play a crucial role in shaping the opinio...
Introduction: In a not-so-distant future, the pharmaceutical industry has embraced the power of arti...
In the healthcare industry, influencers and opinion leaders play a crucial role in shaping the opini...